Patients with rheumatological diseases should routinely be tested for aquaporin-4 (AQP4) antibodies: Commentary

Abstract

Get full access to this article

View all access options for this article.

References

Siriratnam

Huda

Butzkueven

, et al. A comprehensive review of the advances in neuromyelitis optica spectrum disorder. Autoimmun Rev 2023; 22(12): 103465.

Krett

Filippatou

Barreras

, et al. ‘Lupus myelitis’ revisited: A retrospective single-center study of myelitis associated with rheumatologic disease. Neurol Neuroimmunol Neuroinflamm 2025; 12(1): e200329.

Papp

Magyari

Aktas

, et al. Worldwide incidence and prevalence of neuromyelitis optica. Neurology 2021; 96(2): 59–77.